Besides them, we counted 3 critical employees of this fund in our database.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight SPR Therapeutics. Among the most successful fund investment fields, there are Medical, Health Care.
The important activity for fund was in 2017. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year.
The standard case for the fund is to invest in rounds with 1 partaker. In the next rounds fund is usually obtained by U.S. Department of Defense.
Related Funds
| Fund Name | Location |
| Allianz Life Insurance | Minneapolis, Minnesota, United States |
| Bioindustrial Innovation Canada | Canada, Ontario, Sarnia |
| DMM.com | Japan, Tokyo |
| Footprint Ventures | Bangalore, India, Karnataka |
| Fusi Capital | China, Shanghai |
| Hongda Ziben | China, Guangdong, Shenzhen |
| IBK-Truben Investment | - |
| INNOventure | Japan, Tokyo |
| JR KYUSHU RAILWAY | Fukuoka, Fukuoka Prefecture, Japan |
| Kaixin Investment | Beijing, Beijing, China |
| Koubei | China, Hangzhou, Zhejiang |
| Mantra Capital | Georgia, Marietta, United States |
| Mars | Mclean, United States, Virginia |
| National Institute of Food and Agriculture | District of Columbia, United States, Washington |
| Pivotal Group | Arizona, Phoenix, United States |
| Rui Mengxi Capital | - |
| Steel Pier Capital Advisors | New York, New York, United States |
| University of Toronto Entrepreneurship | Canada, Ontario, Toronto |
| Xinjiang Guanghui Chelianwang Touzi Guanli Youxian Gongsi | China, Ürümqi, Xinjiang |
| ZenPharma Limited | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Aria CV | $31M | 25 Feb 2020 | Saint Paul, Minnesota, United States | ||
SPR Therapeutics | $25M | 12 Sep 2017 | Cleveland, Ohio, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Aria CV | $31M | 25 Feb 2020 | Saint Paul, Minnesota, United States | ||
SPR Therapeutics | $25M | 12 Sep 2017 | Cleveland, Ohio, United States |
